August 2, 2017 — Daiichi Sankyo and Forest Laboratories will pay a $300 million settlement to over 2,300 people who suffered sprue-like enteropathy after taking Benicar (olmesartan) for high blood pressure.
The settlement will resolve 2,000 federal lawsuits in a Multi-District Litigation (MDL No. 2606) in New Jersey and hundreds of state-level lawsuits.
The payout amounts will depend on how long the person was hospitalized and whether they have permanent intestinal damage. For more information, visit Olmesartan Product Liability Litigation Settlement.
Sprue-like enteropathy was identified as a side effect of Benicar in August 2012, when Dr. Joseph Murray of the Mayo Clinic reported 22 cases. All of the patients improved when they stopped taking Benicar.
In July 2013, the FDA issued a Safety Communication to warn doctors and patients about the risk. In some cases, diarrhea symptoms did not appear for months or years.
Since experts were not aware of the risk until recently, many patients were misdiagnosed with Celiac disease and developed permanent intestinal damage (villous atrophy), malnutrition, and health problems.
Lawyers say Daiichi Sankyo knew — or should have known — about the risk of enteropathy from Benicar, but failed to warn about the risk. Daiichi Sankyo did not admit liability in the settlement and issued a statement denying any wrongdoing, but said “a settlement is in the best interests of all” so they can move forward and focus on priorities.
Do I have a Benicar Lawsuit?
The Schmidt Firm, PLLC is currently accepting Benicar induced injury cases in all 50 states. If you or somebody you know has been diagnosed with sprue-like enteropathy, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.